RB1 and breast cancer: It was determined that breast cancer patients with mutated Rb given three different regimens of chemotherapy (5-flurouracil/adriamycin/cytoxan, taxane/adriamycin/cytoxan, and taxane/5-flurouracil/adriamycin/cytoxan) generally had a complete response to treatment.